Clinical development and potential of photothermal and photodynamic therapies for cancer

[1]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[2]  P. Nakaji,et al.  Laser interstitial thermal therapy in gliomas. , 2020, Cancer letters.

[3]  Quentin Liu,et al.  Photodynamic therapy with methyl-5-aminolevulinate for basal cell carcinoma: A systematic review and meta-analysis. , 2020, Photodiagnosis and photodynamic therapy.

[4]  Michael R Hamblin,et al.  Photodynamic Therapy for Cancer: What's Past is Prologue , 2019, Photochemistry and photobiology.

[5]  T. Yano,et al.  Role of photodynamic therapy in the treatment of esophageal cancer , 2019, Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society.

[6]  Jon A. Schwartz,et al.  Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study , 2019, Proceedings of the National Academy of Sciences.

[7]  Carl J. Fisher,et al.  Photodynamic Therapy for the Treatment of Vertebral Metastases: A Phase I Clinical Trial , 2019, Clinical Cancer Research.

[8]  Shi Gao,et al.  Photoacoustic imaging and photothermal therapy in the second near-infrared window , 2019, New Journal of Chemistry.

[9]  W. Tan,et al.  Sequential Protein-Responsive Nanophotosensitizer Complex for Enhancing Tumor-Specific Therapy. , 2019, ACS nano.

[10]  Chunhuan Jiang,et al.  A C5 N2 Nanoparticle Based Direct Nucleus Delivery Platform for Synergistic Cancer Therapy. , 2019, Angewandte Chemie.

[11]  Rui Tian,et al.  Near‐Infrared‐II Molecular Dyes for Cancer Imaging and Surgery , 2019, Advanced materials.

[12]  P. Delaere,et al.  Photodynamic therapy in head and neck cancer: indications, outcomes, and future prospects , 2019, Current opinion in otolaryngology & head and neck surgery.

[13]  Z. Dai,et al.  Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer. , 2019, Chemical Society reviews.

[14]  X. Xia,et al.  Low Power Single Laser Activated Synergistic Cancer Phototherapy Using Photosensitizer Functionalized Dual Plasmonic Photothermal Nanoagents. , 2019, ACS nano.

[15]  H Stepp,et al.  5-aminolevulinic acid photodynamic therapy for the treatment of high-grade gliomas , 2019, Journal of Neuro-Oncology.

[16]  Yin Dou,et al.  A self-illuminating nanoparticle for inflammation imaging and cancer therapy , 2019, Science Advances.

[17]  Wenbin Lin,et al.  Nanoscale metal-organic frameworks for mitochondria-targeted radiotherapy-radiodynamic therapy , 2018, Nature Communications.

[18]  Junghan Lee,et al.  Clinical development of photodynamic agents and therapeutic applications , 2018, Biomaterials Research.

[19]  Kanyi Pu,et al.  Recent Progresses in Phototherapy‐Synergized Cancer Immunotherapy , 2018, Advanced Functional Materials.

[20]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[21]  Juyoung Yoon,et al.  Innovative Strategies for Hypoxic-Tumor Photodynamic Therapy. , 2018, Angewandte Chemie.

[22]  E. Monteiro,et al.  Treatment of Head and Neck Cancer with Photodynamic Therapy with Redaporfin: A Clinical Case Report , 2018, Case Reports in Oncology.

[23]  Dalong Ni,et al.  Pyroelectric nanoplatform for NIR-II-triggered photothermal therapy with simultaneous pyroelectric dynamic therapy , 2018 .

[24]  C. Berking,et al.  A randomized, multinational, noninferiority, phase III trial to evaluate the safety and efficacy of BF‐200 aminolaevulinic acid gel vs. methyl aminolaevulinate cream in the treatment of nonaggressive basal cell carcinoma with photodynamic therapy , 2018, The British journal of dermatology.

[25]  C. Hadjipanayis,et al.  Fluorescence‐guided surgery for high‐grade gliomas , 2018, Journal of surgical oncology.

[26]  Arne Juette,et al.  Phase 2 Open-Label Trial Investigating Percutaneous Laser Ablation for Treatment of Early-Stage Breast Cancer: MRI, Pathology, and Outcome Correlations , 2018, Annals of Surgical Oncology.

[27]  Juyoung Yoon,et al.  Phthalocyanine-Assembled Nanodots as Photosensitizers for Highly Efficient Type I Photoreactions in Photodynamic Therapy. , 2018, Angewandte Chemie.

[28]  C. Morton,et al.  Daylight Photodynamic Therapy for Actinic Keratoses , 2018, American Journal of Clinical Dermatology.

[29]  B. Liu,et al.  Aggregation-Induced Emission (AIE) Dots: Emerging Theranostic Nanolights. , 2018, Accounts of chemical research.

[30]  R. Haidry,et al.  Long-term outcomes of the randomized controlled trial comparing 5-aminolaevulinic acid and Photofrin photodynamic therapy for Barrett’s oesophagus related neoplasia , 2018, Scandinavian journal of gastroenterology.

[31]  Libo Li,et al.  Sonodynamic therapy‐assisted immunotherapy: A novel modality for cancer treatment , 2018, Cancer science.

[32]  Jong Seung Kim,et al.  Organic molecule-based photothermal agents: an expanding photothermal therapy universe. , 2018, Chemical Society reviews.

[33]  Z. Tian,et al.  Nanotechnology for Cancer Therapy Based on Chemotherapy , 2018, Molecules.

[34]  K. Nam,et al.  Facile Supramolecular Approach to Nucleic-Acid-Driven Activatable Nanotheranostics That Overcome Drawbacks of Photodynamic Therapy. , 2017, ACS nano.

[35]  F. Bolze,et al.  Molecular photosensitisers for two-photon photodynamic therapy. , 2017, Chemical communications.

[36]  M. Preul,et al.  Laser application in neurosurgery , 2017, Surgical neurology international.

[37]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[38]  Tao Yang,et al.  Bifunctional Tellurium Nanodots for Photo-Induced Synergistic Cancer Therapy. , 2017, ACS nano.

[39]  Juyoung Yoon,et al.  Phthalocyanines as medicinal photosensitizers: Developments in the last five years , 2017, Coordination Chemistry Reviews.

[40]  Chulhong Kim,et al.  Nanostructured Phthalocyanine Assemblies with Protein-Driven Switchable Photoactivities for Biophotonic Imaging and Therapy. , 2017, Journal of the American Chemical Society.

[41]  Juyoung Yoon,et al.  A Tumor-pH-Responsive Supramolecular Photosensitizer for Activatable Photodynamic Therapy with Minimal In Vivo Skin Phototoxicity , 2017, Theranostics.

[42]  Juyoung Yoon,et al.  Cancer‐Associated, Stimuli‐Driven, Turn on Theranostics for Multimodality Imaging and Therapy , 2017, Advanced materials.

[43]  Tianfu Wang,et al.  Enhanced Afterglow Performance of Persistent Luminescence Implants for Efficient Repeatable Photodynamic Therapy. , 2017, ACS nano.

[44]  E. Monteiro,et al.  A first in human study using photodynamic therapy with Redaporfin in advanced head and neck cancer. , 2017 .

[45]  T. Skwor,et al.  Photosensitizers in prostate cancer therapy , 2017, Oncotarget.

[46]  C. Mosse,et al.  Photodynamic therapy: Inception to application in breast cancer. , 2017, Breast.

[47]  I. Yang,et al.  Laser neurosurgery: A systematic analysis of magnetic resonance-guided laser interstitial thermal therapies , 2017, Journal of Clinical Neuroscience.

[48]  Antonio Alcaraz,et al.  Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial. , 2017, The Lancet. Oncology.

[49]  E. Akkaya,et al.  Activatable Photosensitizers: Agents for Selective Photodynamic Therapy , 2017 .

[50]  Sabrina Oliveira,et al.  Oncologic Photodynamic Therapy: Basic Principles, Current Clinical Status and Future Directions , 2017, Cancers.

[51]  Evgueni Parilov,et al.  Interstitial Photodynamic Therapy—A Focused Review , 2017, Cancers.

[52]  Liangzhu Feng,et al.  Theranostic Liposomes with Hypoxia-Activated Prodrug to Effectively Destruct Hypoxic Tumors Post-Photodynamic Therapy. , 2017, ACS nano.

[53]  Jonathan F. Lovell,et al.  Targeted Nanomaterials for Phototherapy , 2017, Nanotheranostics.

[54]  F. Danhier,et al.  To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine? , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[55]  B. Alekseev,et al.  5-Aminolevulinic acid in intraoperative photodynamic therapy of bladder cancer (results of multicenter trial). , 2016, Photodiagnosis and photodynamic therapy.

[56]  Peng Huang,et al.  Overcoming the Achilles' heel of photodynamic therapy. , 2016, Chemical Society reviews.

[57]  Xiu‐Ping Yan,et al.  Conjugation of a photosensitizer to near infrared light renewable persistent luminescence nanoparticles for photodynamic therapy. , 2016, Chemical communications.

[58]  Ligeng Xu,et al.  Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy , 2016, Nature Communications.

[59]  Peter K. Lee,et al.  Photodynamic Therapy for Non-Melanoma Skin Cancers , 2016, Cancers.

[60]  Nuria Oliva,et al.  Local triple-combination therapy results in tumour regression and prevents recurrence in a colon cancer model. , 2016, Nature materials.

[61]  Kai Yang,et al.  Ultrasound Triggered Tumor Oxygenation with Oxygen-Shuttle Nanoperfluorocarbon to Overcome Hypoxia-Associated Resistance in Cancer Therapies. , 2016, Nano letters.

[62]  Sung‐Wook Choi,et al.  Selective Photothermal Tumor Therapy Using Nanodiamond‐Based Nanoclusters with Folic Acid , 2016 .

[63]  K. Berg,et al.  Disulfonated tetraphenyl chlorin (TPCS2a)-induced photochemical internalisation of bleomycin in patients with solid malignancies: a phase 1, dose-escalation, first-in-man trial. , 2016, The Lancet. Oncology.

[64]  Kaikai Wang,et al.  Self-assembled IR780-loaded transferrin nanoparticles as an imaging, targeting and PDT/PTT agent for cancer therapy , 2016, Scientific Reports.

[65]  Jonathan F. Lovell,et al.  Chemophototherapy: An Emerging Treatment Option for Solid Tumors , 2016, Advanced science.

[66]  Mitchel S Berger,et al.  A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas. , 2016, Journal of neurosurgery.

[67]  Tayyaba Hasan,et al.  Revisiting photodynamic therapy dosimetry: reductionist & surrogate approaches to facilitate clinical success , 2016, Physics in medicine and biology.

[68]  D. Eisen,et al.  Daylight Photodynamic Therapy: What Is Known and What Is Yet to Be Determined , 2016, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[69]  E. Akkaya,et al.  A Bifunctional Photosensitizer for Enhanced Fractional Photodynamic Therapy: Singlet Oxygen Generation in the Presence and Absence of Light. , 2016, Angewandte Chemie.

[70]  C. Chiang,et al.  Nucleus‐Targeting Gold Nanoclusters for Simultaneous In Vivo Fluorescence Imaging, Gene Delivery, and NIR‐Light Activated Photodynamic Therapy , 2015 .

[71]  Thomas S. Mang,et al.  Photodynamic therapy (PDT) for malignant brain tumors--where do we stand? , 2015, Photodiagnosis and photodynamic therapy.

[72]  Xianfeng Chen,et al.  Combined chemotherapy and photodynamic therapy using a nanohybrid based on layered double hydroxides to conquer cisplatin resistance. , 2015, Chemical communications.

[73]  D. Kessel,et al.  Promotion of Proapoptotic Signals by Lysosomal Photodamage , 2015, Photochemistry and photobiology.

[74]  S. Shumack,et al.  Consensus recommendations on the use of daylight photodynamic therapy with methyl aminolevulinate cream for actinic keratoses in Australia , 2015, The Australasian journal of dermatology.

[75]  Jie Yu,et al.  Smart MoS2/Fe3O4 Nanotheranostic for Magnetically Targeted Photothermal Therapy Guided by Magnetic Resonance/Photoacoustic Imaging , 2015, Theranostics.

[76]  Samuel Achilefu,et al.  Breaking the Depth Dependency of Phototherapy with Cerenkov Radiation and Low Radiance Responsive Nanophotosensitizers , 2015, Nature nanotechnology.

[77]  K. Soo,et al.  Nanoparticles in photodynamic therapy. , 2015, Chemical reviews.

[78]  Wenbin Lin,et al.  Self-assembled core-shell nanoparticles for combined chemotherapy and photodynamic therapy of resistant head and neck cancers. , 2015, ACS nano.

[79]  Lothar Lilge,et al.  Photodynamic therapy in the treatment of intracranial gliomas: A review of current practice and considerations for future clinical directions , 2015 .

[80]  Charles B Simone,et al.  Photodynamic therapy for lung cancer and malignant pleural mesothelioma. , 2014, Seminars in oncology.

[81]  Eric C Leuthardt,et al.  Stereotactic laser ablation of high-grade gliomas. , 2014, Neurosurgical focus.

[82]  Wei Wang,et al.  Iron/iron oxide core/shell nanoparticles for magnetic targeting MRI and near-infrared photothermal therapy. , 2014, Biomaterials.

[83]  Jennifer Y. Lin,et al.  Current evidence and applications of photodynamic therapy in dermatology , 2014, Clinical, cosmetic and investigational dermatology.

[84]  A. Oto,et al.  Laser ablation as focal therapy for prostate cancer , 2014, Current opinion in urology.

[85]  P. Prasad,et al.  Upconversion Nanoparticles: Design, Nanochemistry, and Applications in Theranostics , 2014, Chemical reviews.

[86]  Xiaoyang Xu,et al.  Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. , 2014, Advanced drug delivery reviews.

[87]  T. Kündig,et al.  Intradermal photosensitisation facilitates stimulation of MHC class-I restricted CD8 T-cell responses of co-administered antigen. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[88]  C. Brace,et al.  Tumor ablation: common modalities and general practices. , 2013, Techniques in vascular and interventional radiology.

[89]  Ronald Sroka,et al.  Photodynamic therapy of bladder cancer - a phase I study using hexaminolevulinate (HAL). , 2013, Urologic oncology.

[90]  Yanqing Hua,et al.  A core/satellite multifunctional nanotheranostic for in vivo imaging and tumor eradication by radiation/photothermal synergistic therapy. , 2013, Journal of the American Chemical Society.

[91]  Zhe Wang,et al.  Single Continuous Wave Laser Induced Photodynamic/Plasmonic Photothermal Therapy Using Photosensitizer‐Functionalized Gold Nanostars , 2013, Advanced materials.

[92]  Shirui Mao,et al.  Smart pH-sensitive and temporal-controlled polymeric micelles for effective combination therapy of doxorubicin and disulfiram. , 2013, ACS nano.

[93]  A. Sidoroff,et al.  European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications – actinic keratoses, Bowen’s disease, basal cell carcinoma , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

[94]  Ronald Sroka,et al.  Protoporphyrin IX Fluorescence and Photobleaching During Interstitial Photodynamic Therapy of Malignant Gliomas for Early Treatment Prognosis , 2013, Lasers in surgery and medicine.

[95]  Harold S. Freeman,et al.  Dye Sensitizers for Photodynamic Therapy , 2013, Materials.

[96]  K. Burgess,et al.  BODIPY dyes in photodynamic therapy. , 2013, Chemical Society reviews.

[97]  H. Wolfsen,et al.  Photodynamic Therapy for Barrett's Esophagus and Esophageal Carcinoma , 2013, Clinical endoscopy.

[98]  C. Shim,et al.  Photodynamic therapy prolongs metal stent patency in patients with unresectable hilar cholangiocarcinoma. , 2012, World journal of gastroenterology.

[99]  Victor M Montori,et al.  Photodynamic therapy for unresectable cholangiocarcinoma: a comparative effectiveness systematic review and meta-analyses. , 2012, Photodiagnosis and photodynamic therapy.

[100]  T. Yano,et al.  Phase I study of photodynamic therapy using talaporfin sodium and diode laser for local failure after chemoradiotherapy for esophageal cancer , 2012, Radiation oncology.

[101]  S. Lipsitz,et al.  Comparative effectiveness of cryotherapy vs brachytherapy for localised prostate cancer , 2012, BJU international.

[102]  Andrea Minervini,et al.  A comparison of hexaminolevulinate (Hexvix®) fluorescence cystoscopy and white-light cystoscopy for detection of bladder cancer: results of the HeRo observational study , 2012, Surgical Endoscopy.

[103]  James F. Leary,et al.  Tumor-targeting hyaluronic acid nanoparticles for photodynamic imaging and therapy. , 2012, Biomaterials.

[104]  A. Filip,et al.  Photodynamic therapy in melanoma--an update. , 2012, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[105]  Kai Yang,et al.  Multifunctional nanoparticles for upconversion luminescence/MR multimodal imaging and magnetically targeted photothermal therapy. , 2012, Biomaterials.

[106]  C. Berking,et al.  Photodynamic therapy with BF‐200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer‐blind phase III study in comparison with a registered methyl‐5‐aminolaevulinate cream and placebo , 2012, The British journal of dermatology.

[107]  Yaping Li,et al.  Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles. , 2011, ACS nano.

[108]  X. Ji,et al.  A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance. , 2011, Biomaterials.

[109]  Even Angell-Petersen,et al.  Disulfonated tetraphenyl chlorin (TPCS_2a), a novel photosensitizer developed for clinical utilization of photochemical internalization , 2011, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[110]  Liangzhu Feng,et al.  Photothermally enhanced photodynamic therapy delivered by nano-graphene oxide. , 2011, ACS nano.

[111]  T. Hasan,et al.  Mechanisms of resistance to photodynamic therapy. , 2011, Current medicinal chemistry.

[112]  Hong Liu,et al.  Preliminary safety and efficacy results of laser immunotherapy for the treatment of metastatic breast cancer patients , 2011, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[113]  David Kessel,et al.  Photodynamic therapy of cancer: An update , 2011, CA: a cancer journal for clinicians.

[114]  B. L. Andersen,et al.  A randomized, multicentre study of directed daylight exposure times of 1½ vs. 2½ h in daylight‐mediated photodynamic therapy with methyl aminolaevulinate in patients with multiple thin actinic keratoses of the face and scalp , 2011, The British journal of dermatology.

[115]  Hisataka Kobayashi,et al.  Cancer Cell-Selective In Vivo Near Infrared Photoimmunotherapy Targeting Specific Membrane Molecules , 2011, Nature Medicine.

[116]  Jun Fang,et al.  The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. , 2011, Advanced drug delivery reviews.

[117]  Michael R Hamblin,et al.  Stimulation of anti-tumor immunity by photodynamic therapy , 2011, Expert review of clinical immunology.

[118]  G. Dolivet,et al.  Temoporfin‐mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: A multicenter study , 2010, Head & neck.

[119]  W. Jerjes,et al.  The surgical palliation of advanced head and neck cancer using photodynamic therapy. , 2010, Clinical oncology (Royal College of Radiologists (Great Britain)).

[120]  J. Buchner,et al.  The heat shock response: life on the verge of death. , 2010, Molecular cell.

[121]  Tayyaba Hasan,et al.  Imaging and photodynamic therapy: mechanisms, monitoring, and optimization. , 2010, Chemical reviews.

[122]  Shu-Jyuan Yang,et al.  Aptamer-based tumor-targeted drug delivery for photodynamic therapy. , 2010, ACS nano.

[123]  Feng Gao,et al.  RGD-conjugated dendrimer-modified gold nanorods for in vivo tumor targeting and photothermal therapy. , 2010, Molecular pharmaceutics.

[124]  Gang Zheng,et al.  Activatable photosensitizers for imaging and therapy. , 2010, Chemical reviews.

[125]  S. Wang,et al.  Talaporfin sodium , 2010, Expert opinion on pharmacotherapy.

[126]  David Woolfson,et al.  Designing photosensitizers for photodynamic therapy: strategies, challenges and promising developments. , 2009, Future medicinal chemistry.

[127]  K. Berg,et al.  Photochemical internalization (PCI) in cancer therapy: from bench towards bedside medicine. , 2009, Journal of photochemistry and photobiology. B, Biology.

[128]  I. Tan,et al.  Is photodynamic therapy a good alternative to surgery and radiotherapy in the treatment of head and neck cancer? , 2009, Photodiagnosis and photodynamic therapy.

[129]  A. Böhle,et al.  [BCG versus photodynamic therapy (PDT) for nonmuscle invasive bladder cancer-a multicentre clinical phase III study]. , 2009, Aktuelle Urologie.

[130]  Wladyslaw Michal Witold Gedroyc,et al.  Laser ablation of hepatocellular carcinoma--a review. , 2008, World journal of gastroenterology.

[131]  Zheng Huang,et al.  An update on the regulatory status of PDT photosensitizers in China. , 2008, Photodiagnosis and photodynamic therapy.

[132]  Naomi J Halas,et al.  Nanoshell-enabled photothermal cancer therapy: impending clinical impact. , 2008, Accounts of chemical research.

[133]  R. Dummer,et al.  A clinical study comparing methyl aminolevulinate photodynamic therapy and surgery in small superficial basal cell carcinoma (8–20 mm), with a 12‐month follow‐up. , 2008, Journal of the European Academy of Dermatology and Venereology : JEADV.

[134]  M. Sam Eljamel,et al.  ALA and Photofrin® Fluorescence-guided resection and repetitive PDT in glioblastoma multiforme: a single centre Phase III randomised controlled trial , 2008, Lasers in Medical Science.

[135]  Francisco Sanz-Rodríguez,et al.  Photodynamic therapy of cancer. Basic principles and applications , 2008, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

[136]  R. Regine,et al.  Complications of laser ablation for hepatocellular carcinoma: a multicenter study. , 2008, Radiology.

[137]  C H Sibata,et al.  Bio-nanotechnology and photodynamic therapy--state of the art review. , 2008, Photodiagnosis and photodynamic therapy.

[138]  J. Karp,et al.  Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .

[139]  M. Biel,et al.  Photodynamic Therapy Treatment of Early Oral and Laryngeal Cancers † , 2007, Photochemistry and photobiology.

[140]  F. Moloney,et al.  Randomized, double‐blind, prospective study to compare topical 5‐aminolaevulinic acid methylester with topical 5‐aminolaevulinic acid photodynamic therapy for extensive scalp actinic keratosis , 2007, The British journal of dermatology.

[141]  A. Andrén-sandberg,et al.  Photodynamic Therapy for Pancreatic Cancer , 2007, Pancreas.

[142]  C. Sibata,et al.  A clinical review of PDT for cutaneous malignancies. , 2006, Photodiagnosis and photodynamic therapy.

[143]  R. Nordquist,et al.  In situ photoimmunotherapy: a tumour‐directed treatment for melanoma , 2006, British Journal of Dermatology.

[144]  Michael R Hamblin,et al.  Photodynamic therapy and anti-tumour immunity , 2006, Nature Reviews Cancer.

[145]  Amy Gryshuk,et al.  Nature: A rich source for developing multifunctional agents. tumor‐imaging and photodynamic therapy , 2006, Lasers in surgery and medicine.

[146]  F. Zanella,et al.  Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. , 2006, The Lancet. Oncology.

[147]  Gunnar Hansen,et al.  Transbronchial laser ablation of benign and malignant tumors , 2006, Minimally invasive therapy & allied technologies : MITAT : official journal of the Society for Minimally Invasive Therapy.

[148]  H. Matsui,et al.  Mechanisms involved in delta-aminolevulinic acid (ALA)-induced photosensitivity of tumor cells: relation of ferrochelatase and uptake of ALA to the accumulation of protoporphyrin. , 2005, Biochemical pharmacology.

[149]  H. Kato,et al.  Locally recurrent central-type early stage lung cancer < 1.0 cm in diameter after complete remission by photodynamic therapy. , 2005, Chest.

[150]  H. Moseley.  Light distribution and calibration of commercial PDT LED arrays , 2005, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[151]  Bergein F Overholt,et al.  Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. , 2005, Gastrointestinal endoscopy.

[152]  Zheng Huang,et al.  A Review of Progress in Clinical Photodynamic Therapy , 2005, Technology in cancer research & treatment.

[153]  Andrew H. Kaye,et al.  Photodynamic therapy of high grade glioma – long term survival , 2005, Journal of Clinical Neuroscience.

[154]  C H Sibata,et al.  PD/PDT for gynecological disease: A clinical review. , 2005, Photodiagnosis and photodynamic therapy.

[155]  C H Sibata,et al.  Clinical PD/PDT in North America: An historical review. , 2004, Photodiagnosis and photodynamic therapy.

[156]  M. Wallace,et al.  Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer , 2004, Alimentary pharmacology & therapeutics.

[157]  I. Tan,et al.  mTHPC‐mediated photodynamic therapy for early oral squamous cell carcinoma , 2004, International journal of cancer.

[158]  J. Brown,et al.  Exploiting tumour hypoxia in cancer treatment , 2004, Nature Reviews Cancer.

[159]  J. Usuda,et al.  Photodynamic therapy (PDT) of lung cancer: experience of the Tokyo Medical University. , 2004, Photodiagnosis and photodynamic therapy.

[160]  C. Hopper,et al.  The cost-effectiveness of Foscan mediated photodynamic therapy (Foscan-PDT) compared with extensive palliative surgery and palliative chemotherapy for patients with advanced head and neck cancer in the UK. , 2004, Oral oncology.

[161]  M. Biel,et al.  mTHPC‐mediated photodynamic therapy in patients with advanced, incurable head and neck cancer: a multicenter study of 128 patients , 2004, Head & neck.

[162]  Martin G Mack,et al.  Colorectal carcinoma metastases in liver: laser-induced interstitial thermotherapy--local tumor control rate and survival data. , 2004, Radiology.

[163]  Kristian Berg,et al.  Photochemical internalisation in drug and gene delivery. , 2004, Advanced drug delivery reviews.

[164]  J. Luketich,et al.  Photodynamic therapy as palliation for esophageal cancer: experience in 215 patients. , 2003, The Annals of thoracic surgery.

[165]  Masaaki Kawahara,et al.  Phase II clinical study of photodynamic therapy using mono-L-aspartyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lung. , 2003, Lung cancer.

[166]  J. Frangioni.  In vivo near-infrared fluorescence imaging. , 2003, Current opinion in chemical biology.

[167]  R. Jain,et al.  Photodynamic therapy for cancer , 2003, Nature Reviews Cancer.

[168]  Martin G Mack,et al.  Malignant liver tumors treated with MR imaging-guided laser-induced thermotherapy: experience with complications in 899 patients (2,520 lesions). , 2002, Radiology.

[169]  Stephen G Bown,et al.  Photodynamic therapy for prostate cancer recurrence after radiotherapy: a phase I study. , 2002, The Journal of urology.

[170]  Paul M. Ripley,et al.  Photodynamic therapy for cancer of the pancreas , 2002, Gut.

[171]  P. Jichlinski,et al.  Photodynamic therapy in superficial bladder cancer: past, present and future , 2001, Urological Research.

[172]  M. Reed,et al.  The History of Photodetection and Photodynamic Therapy¶ , 2001, Photochemistry and photobiology.

[173]  A. Oseroff,et al.  Mitochondria-based photodynamic anti-cancer therapy. , 2001, Advanced drug delivery reviews.

[174]  N. Bendsoe,et al.  Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial , 2001, The British journal of dermatology.

[175]  B. Overholt,et al.  Results of photodynamic therapy for ablation of dysplasia and early cancer in Barrett's esophagus and effect of oral steroids on stricture formation , 2000, American Journal of Gastroenterology.

[176]  D. D. De Vos,et al.  A comparative study of the photosensitizing characteristics of some cyanine dyes. , 2000, Journal of photochemistry and photobiology. B, Biology.

[177]  C. M. Allen,et al.  Photodynamic therapeutics: basic principles and clinical applications. , 1999, Drug discovery today.

[178]  E. Farrero,et al.  Efficacy and safety of photodynamic therapy versus Nd-YAG laser resection in NSCLC with airway obstruction. , 1999, The European respiratory journal.

[179]  N. Oleinick,et al.  The photobiology of photodynamic therapy: cellular targets and mechanisms. , 1998, Radiation research.

[180]  Haines.  What's past is prologue , 1998, The Canadian nurse.

[181]  M. Kohl,et al.  Near-infrared optical properties of ex vivo human skin and subcutaneous tissues measured using the Monte Carlo inversion technique. , 1998, Physics in medicine and biology.

[182]  R. Kaufmann.  Photodynamic therapy for non-melanoma skin cancer , 1998 .

[183]  H. Bergh.  On the evolution of some endoscopic light delivery systems for photodynamic therapy , 1998 .

[184]  S. Steinberg,et al.  Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma , 1997, Annals of Surgical Oncology.

[185]  A. S. Sobolev,et al.  Nuclear Targeting of Chlorin e6 Enhances Its Photosensitizing Activity* , 1997, The Journal of Biological Chemistry.

[186]  M. Ferguson,et al.  Mortality after Esophagectomy: Risk Factor Analysis , 1997, World Journal of Surgery.

[187]  J. Nelson,et al.  Photodynamic therapy of actinic keratosis with topical 5-aminolevulinic acid. A pilot dose-ranging study. , 1997, Archives of dermatology.

[188]  R. Nordquist,et al.  Laser-photosensitizer assisted immunotherapy: a novel modality for cancer treatment. , 1997, Cancer letters.

[189]  M. Wainwright.  Non-porphyrin photosensitizers in biomedicine , 1997 .

[190]  H Anholt,et al.  Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture. , 1997, Cancer research.

[191]  C. Whitehurst,et al.  Comparison of photodynamic therapy with cryotherapy in the treatment of Bowen's disease , 1996, The British journal of dermatology.

[192]  H. Kato,et al.  Photodynamic therapy for early stage bronchogenic carcinoma. , 1996, Journal of clinical laser medicine & surgery.

[193]  B. Overholt,et al.  Photodynamic therapy with porfimer sodium versus thermal ablation therapy with Nd:YAG laser for palliation of esophageal cancer: a multicenter randomized trial. , 1995, Gastrointestinal endoscopy.

[194]  T. Taguchi,et al.  [Phase I study]. , 1995, Gan to kagaku ryoho. Cancer & chemotherapy.

[195]  R. Lambert,et al.  Long-term survival after photodynamic therapy for esophageal cancer. , 1995, Gastroenterology.

[196]  Steven B. Johnson,et al.  RESULTS OF A PHASE III CLINICAL TRIAL OF THE HUMAN MONOCLONAL ANTIBODY MAB‐T88 VERSUS PLACEBO IN GRAM NEGATIVE SEPSIS. , 1995 .

[197]  T. Onat.  Clinical Case Report , 1994, Human Genetics.

[198]  T. Dougherty.  PHOTODYNAMIC THERAPY , 1993, Clinics in chest medicine.

[199]  T. Okunaka,et al.  A prospective phase II study on photodynamic therapy with photofrin II for centrally located early-stage lung cancer. The Japan Lung Cancer Photodynamic Therapy Study Group. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[200]  J. Hill,et al.  A history of photodynamic therapy. , 1991, The Australian and New Zealand journal of surgery.

[201]  H. Pass,et al.  INTRAVENOUS vs INTRAPERITONEAL SENSITIZER: IMPLICATIONS FOR INTRAPERITONEAL PHOTODYNAMIC THERAPY , 1991, Photochemistry and photobiology.

[202]  R. Sultan.  Tumour ablation by laser in general surgery , 1990, Lasers in Medical Science.

[203]  J. Kennedy,et al.  Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. , 1990, Journal of photochemistry and photobiology. B, Biology.

[204]  T. Delaney,et al.  Photodynamic therapy of cancer. , 1988, Comprehensive therapy.

[205]  J. Leriche,et al.  A RANDOMIZED COMPARATIVE STUDY OF THE SAFETY and EFFICACY OF PHOTODYNAMIC THERAPY USING PHOTOFRIN II COMBINED WITH PALLIATIVE RADIOTHERAPY VERSUS PALLIATIVE RADIOTHERAPY ALONE IN PATIENTS WITH INOPERABLE OBSTRUCTIVE NON‐SMALL CELL BRONCHOGENIC CARCINOMA , 1987, Photochemistry and photobiology.

[206]  M L Yarmush,et al.  STRATEGIES FOR SELECTIVE CANCER PHOTOCHEMOTHERAPY: ANTIBODY‐TARGETED and SELECTIVE CARCINOMA CELL PHOTOLYSIS * , 1987, Photochemistry and photobiology.

[207]  M. Berns,et al.  Photoradiation therapy of head and neck cancer , 1984, Progress in clinical and biological research.

[208]  J. Levy,et al.  Photoimmunotherapy: treatment of animal tumors with tumor-specific monoclonal antibody-hematoporphyrin conjugates. , 1983, Journal of immunology.

[209]  J E Kaufman,et al.  Photoradiation therapy for the treatment of malignant tumors. , 1978, Cancer research.

[210]  Leon Goldman,et al.  A review: Applications of the laser beam in cancer biology , 1966 .

[211]  N. S. Kapany,et al.  Retinal Photocoagulation by Lasers , 1963, Nature.

[212]  T. Maiman.  Stimulated Optical Radiation in Ruby , 1960, Nature.

[213]  G. Fraedrich,et al.  Juvenile recurrent respiratory papillomatosis: Still a mystery disease with difficult management , 2007, Head & neck.

[214]  Jui-Teng Lin.  Progress of medical lasers: Fundamentals and Applications , 2016 .

[215]  S. Bown.  Photodynamic therapy for cancer of the pancreas – The story so far , 2016 .

[216]  Tanja Sušec,et al.  Historical Review , 1917, Acta Cytologica.

[217]  G. Martin.  A randomized, multicentre study of directed daylight exposure times of 1½ vs. 2½h in daylight-mediated photodynamic therapy with methyl aminolaevulinate in patients with multiple thin actinic keratoses of the face and scalp , 2012 .

[218]  Manivannan Ethirajan,et al.  The role of porphyrin chemistry in tumor imaging and photodynamic therapy. , 2011, Chemical Society reviews.

[219]  M. Biel,et al.  Photodynamic therapy of head and neck cancers. , 2010, Methods in molecular biology.

[220]  Mark Emberton,et al.  Photodynamic therapy for prostate cancer—a review of current status and future promise , 2009, Nature Clinical Practice Urology.

[221]  Mohd Fahad Ullah,et al.  Cancer multidrug resistance (MDR): a major impediment to effective chemotherapy. , 2008, Asian Pacific journal of cancer prevention : APJCP.

[222]  D. Holdstock.  Past, present--and future? , 2005, Medicine, conflict, and survival.

[223]  John E. Moulder,et al.  Tumor hypoxia: its impact on cancer therapy , 2004, Cancer and Metastasis Reviews.

[224]  Kevin J. Bozic,et al.  Basic principles and clinical applications , 2004 .

[225]  Jean-Jacques Grob,et al.  Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. , 2004, Archives of dermatology.

[226]  H. Kato,et al.  Photodynamic therapy for peripheral lung cancer. , 2004, Lung cancer.

[227]  G. Snow,et al.  Basic principles, applications in oncology and improved selectivity of photodynamic therapy. , 2003, Anticancer research.

[228]  C M Allen,et al.  Role of activated oxygen species in photodynamic therapy. , 2000, Methods in enzymology.

[229]  Allen Cm,et al.  Role of activated oxygen species in photodynamic therapy. , 2000 .

[230]  K. Moghissi,et al.  The place of bronchoscopic photodynamic therapy in advanced unresectable lung cancer: experience of 100 cases. , 1999, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[231]  S. Sikdar,et al.  Fundamentals and applications , 1998 .

[232]  T. Dougherty.  Photodynamic therapy. , 1993, Photochemistry and photobiology.

[233]  Masoud Panjehpour,et al.  Centering balloon to improve esophageal photodynamic therapy , 1992, Lasers in surgery and medicine.

[234]  P. Oehr,et al.  [Clinical use of photodynamic therapy in gynecologic tumor patients--antibody-targeted photodynamic laser therapy as a new oncologic treatment procedure]. , 1992, Zentralblatt fur Gynakologie.

[235]  Michele T. Cooper,et al.  Cutaneous phototoxic occurrences in patients receiving Photofrin® , 1990, Lasers in surgery and medicine.

[236]  O. Balchum,et al.  HpD photodynamic therapy for obstructing lung cancer. , 1984, Progress in clinical and biological research.

[237]  K. Johnson.  An Update. , 1984, Journal of food protection.

[238]  W. Kannel,et al.  Risk factor analysis. , 1984, Progress in cardiovascular diseases.